After opening on a strong note this morning, the ASX 200 faded into the afternoon, retreating from a three-week high to close ...
Percheron Therapeutics regroups after clinical trial results; vows to continue to conserve cash and develop pipeline ...
New data shows the 40 key ASX biotechs gained an average 50% in 2024 - but not all of them joined the winner's circle.
Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in precision diagnostics, is pleased to announce that its subsidiary OxiDx Pty Ltd ...
Morgans analyst Iain Wilkie said 2024 was "pretty patchy" for the ASX healthcare sector, which underperformed broader markets ...
A Proteomics International subsidiary has unveiled a novel fingerprick test to track muscle damage in elite runners, ...
If you thought crypto investors need to have strong stomachs, spare a thought for the investors who try their luck in the ...
The local sharemarket opened just six points higher in Tuesday’s shortened trading session as a tech-powered rally on Wall ...
Avita Medical has announced FDA approval for its new RECELL GO mini disposable cartridge. Spray-on skin The original RECELL platform received FDA approval in 2018 for severe burns ...
ASX rebounds as CBA rallies, News Corp sells Foxtel Bargain hunters have stepped in after two days of heavy selling, sending the banking sector higher near noon AEDT. Rupert Murdoch’s media company ...
Muscle testing is also known as applied kinesiology (AK) or manual muscle testing (MMT). It is an alternative medicine practice that claims to effectively diagnose structural, muscular, chemical ...
Stockhead on MSN18d
Scott Power: Which stock fell off its perch on poor trial results this week?Percheron shares tumbled on negative Duchenne muscular dystrophy phase 2b trial results this week EBR Systems edged closer to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback